KalVista Pharmaceuticals to Present Data at the 2023 Meeting of the European Academy of Allergy and Clinical Immunology (EAACI)

KalVista Pharmaceuticals, Inc. announced the acceptance of multiple abstracts at the 2023 European Academy of Allergy and Clinical Immunology Congress, taking place in Hamburg, Germany and virtually, from June 9-11.

Scroll to Top